Table 2.
Age Decade, yb | ||||
---|---|---|---|---|
Cerebrovascular Pathologic Evaluation |
50–59 | 60–69 | 70–79 | 80–89 |
All Patients, Prevalence (95% CI) | ||||
WMH | — | 5.2 (3.0–7.3) | 16.5 (12.4–20.7) | 47.5 (38.5–56.6) |
Total CMB | 7.0 (4.0–10.1) | 10.3 (7.3–13.3) | 18.8 (14.6–23.1) | 34.8 (26.9–42.7) |
Deep CMB | 0.2 (0.0–0.7) | 2.2 (0.7–3.6) | 5.2 (2.9–7.5) | 8.1 (3.2–13.0) |
Lobar CMB | 6.6 (3.7–9.6) | 8.0 (5.3–10.6) | 15.3 (11.4–19.2) | 27.3 (20.2–34.3) |
Total infarct | 2.7 (0.9–4.4) | 8.5 (5.8–11.1) | 17.3 (13.2–21.4) | 39.8 (30.5–49.1) |
Lacunar infarct | 1.7 (0.3–3.1) | 6.7 (4.4–9.0) | 11.3 (8.1–14.5) | 26.1 (18.3–33.9) |
Cortical infarct | 0.6 (0.0–1.5) | 2.1 (1.0–3.3) | 6.0 (3.3–8.6) | 18.4 (8.5–28.2) |
Men, Prevalence (95% CI) | ||||
WMH | — | 4.5 (1.9–7.0) | 11.2 (6.8–15.7) | 50.0 (37.0–63.1) |
Total CMB | 8.5 (3.8–13.2) | 15.1 (9.9–20.2) | 22.3 (16.1–28.6) | 37.7 (26.5–49.0) |
Deep CMB | 0.5 (0.0–1.4) | 3.3 (0.5–6.1) | 5.4 (2.2–8.6) | 6.2 (1.7–10.7) |
Lobar CMB | 8.5 (3.8–13.2) | 12.0 (7.4–16.7) | 19.5 (13.6–25.5) | 30.5 (20.8–40.3) |
Total infarct | 4.3 (1.1–7.5) | 10.7 (6.8–14.5) | 21.3 (15.2–27.3) | 46.7 (33.1–60.2) |
Lacunar infarct | 2.3 (0.0–4.7) | 9.1 (5.5–12.8) | 16.5 (11.0–22.0) | 28.4 (16.3–40.4) |
Cortical infarct | 1.3 (0.0–3.2) | 3.0 (1.0–5.0) | 7.1 (3.5–10.7) | 27.3 (10.4–44.2) |
Women, Prevalence (95% CI) | ||||
WMH | — | 5.8 (2.4–9.1) | 21.0 (14.3–27.7) | 45.1 (32.8–57.4) |
Total CMB | 5.7 (1.7–9.7) | 6.2 (2.9–9.6) | 15.9 (10.1–21.7) | 32.0 (20.1–43.8) |
Deep CMB | — | 1.2 (0.0–2.4) | 5.1 (1.8–8.4) | 9.9 (1.4–18.4) |
Lobar CMB | 5.0 (1.2–8.7) | 4.5 (1.7–7.2) | 11.7 (6.5–17.0) | 24.1 (13.5–34.6) |
Total infarct | 1.2 (0.0–2.8) | 6.6 (2.9–10.3) | 14.0 (8.3–19.6) | 32.8 (21.5–44.0) |
Lacunar infarct | 1.2 (0.0–2.8) | 4.5 (1.6–7.5) | 6.9 (3.1–10.7) | 28.4 (16.3–40.4) |
Cortical infarct | — | 1.4 (0.0–2.8) | 5.0 (1.1–8.9) | 9.7 (2.5–16.8) |
Abbreviations: CI= confidence interval; CMB=cerebral microbleed; WMH=white-matter hyperintensity.
Dash indicates no data available.